A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements

Pathology Oncology Research : POR
Marie JarosovaTomas Papajik

Abstract

BCL6 rearrangements (3q27) are the most common chromosomal abnormalities in diffuse large B-cell lymphoma (DLBCL), with numerous immunoglobulin (Ig) and non-Ig genes as partners. In DLBCL, the translocations occur predominantly in the "major breakpoint region" encompassing the first noncoding exon and a part of the first intron of BCL6; few cases with "alternative breakpoint cluster" located 245-285 kb 5' BCL6 were also described. The regulatory sequences of known Ig and non-Ig partners replace the 5' untranslated region of the BCL6 in the same transcriptional orientation. Contrary to Ig/BCL6 fusions typical by high BCL6 gene expression, in non-Ig/BCL6 translocations were observed unexpectedly low BCL6 mRNA levels. From the clinical point of view, the survival rate of DLBCL patients with non-Ig partners is inferior to those with Ig/BCL6 translocations, suggesting that non-Ig/BCL6 fusion is a poor prognostic indicator. Hereby we provide comprehensive information about known non-Ig translocation partners and clinical consequences of BCL6 rearrangements in DLBCL. Moreover, we describe a novel reciprocal translocation t(3;10) in refractory patient with DLBCL with the breaking points at 5' untranslated region of BCL6 and 5' untransl...Continue Reading

References

Jan 1, 1992·British Journal of Haematology·V MikrakiR S Chaganti
Sep 1, 1984·Cancer Genetics and Cytogenetics·J J YunisM E Kaplan
Dec 1, 1995·International Journal of Hematology·S UtsumiA Yamaguchi
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·C C ChangR Dalla-Favera
May 1, 1997·Annals of Hematology·I MiuraA B Miura
Mar 25, 1999·European Journal of Haematology·M JerkemanF Mitelman
May 8, 1999·British Journal of Haematology·W Y AuD E Horsman
Feb 13, 2003·Cancer Genetics and Cytogenetics·Prasanna KumariTambarahalli S Sundareshan
Jun 14, 2003·The EMBO Journal·Jaime Font de MoraEugenio Santos
Apr 30, 2004·The New England Journal of Medicine·Izidore S LossosRonald Levy
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chainarong TunyaplinKathryn L Calame
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sílvia BeàElias Campo
Dec 4, 2004·Nature·Ryan T Phan, Riccardo Dalla-Favera
Apr 27, 2005·Genes, Chromosomes & Cancer·José Ignacio Martín-SuberoReiner Siebert
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katsuaki UraYoichi Furukawa
Dec 5, 2006·Journal of Clinical and Experimental Hematopathology : JCEH·Hitoshi Ohno
Sep 25, 2007·Cancer Genetics and Cytogenetics·J IqbalP Koduru
Nov 9, 2007·Leukemia·B SchneiderR A F MacLeod
Aug 23, 2008·Genes, Chromosomes & Cancer·Nathalie A JohnsonDouglas E Horsman

❮ Previous
Next ❯

Citations

Jul 4, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liancheng ZhuBei Lin
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Song GaoBei Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.